The Library
Serum selenium concentrations and hypertension in the US population
Tools
Laclaustra, Martin, Navas-Acien, Ana, Stranges, Saverio, Ordovas, J. M. and Guallar, Eliseo. (2009) Serum selenium concentrations and hypertension in the US population. Circulation: Cardiovascular Quality and Outcomes, Vol.2 (No.4). pp. 369-376. ISSN 1941-7713
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1161/CIRCOUTCOMES.108.831552
Abstract
Background - Selenium is an antioxidant micronutrient with potential interest for cardiovascular disease prevention. Few studies have evaluated the association between selenium and hypertension, with inconsistent findings. We explored the relationship of serum selenium concentrations with blood pressure and hypertension in a representative sample of the US population. Methods and Results - We undertook a cross-sectional analysis of 2638 adults >= 40 years old who participated in the 2003 to 2004 National Health and Nutrition Examination Survey. Serum selenium was measured by inductively coupled plasma-dynamic reaction cell-mass spectrometry. Hypertension was defined as blood pressure >= 140/90 mm Hg or current use of antihypertensive medication. Mean serum selenium was 137.1 mu g/L. The multivariable adjusted ;differences (95% CIs) in blood pressure levels comparing the highest (>= 150 mu g/L) to the lowest (<122 mu g/L) quintile of serum selenium were 4.3 (1.3 to 7.4), 1.6 (-0.5 to 3.7), and 2.8 (0.8 to 4.7) mm Hg for systolic, diastolic, and pulse pressure, respectively. The corresponding odds ratio for hypertension was 1.73 (1.18 to 2.53). In spline regression models, blood pressure levels and the prevalence of hypertension increased with increasing selenium concentrations up to 160 mu g/L. Conclusions - High serum selenium concentrations were associated with higher prevalence of hypertension. These findings call for a thorough evaluation of the risks and benefits associated with high selenium status in the United States. (Circ Cardiovasc Qual Outcomes. 2009;2:369-376.)
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QP Physiology R Medicine > RA Public aspects of medicine R Medicine > RC Internal medicine |
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
| Library of Congress Subject Headings (LCSH): | Selenium -- Physiological effect -- Research, Blood lipids, Hypertension -- Pathogenesis, Nutrition, National Health and Nutrition Examination Survey (U.S.), Selenium -- Analysis -- United States -- Statistics, Selenium in human nutrition -- Analysis -- United States -- Statistics |
| Journal or Publication Title: | Circulation: Cardiovascular Quality and Outcomes |
| Publisher: | Lippincott Williams & Wilkins |
| ISSN: | 1941-7713 |
| Date: | July 2009 |
| Volume: | Vol.2 |
| Number: | No.4 |
| Number of Pages: | 8 |
| Page Range: | pp. 369-376 |
| Identification Number: | 10.1161/CIRCOUTCOMES.108.831552 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Funder: | National Institute of Environmental Health Sciences (NIEHS), American Heart Association (AHA) |
| Grant number: | 1 R01 ES012673 (NIEHS), 0230232N (AHA) |
| References: | 1. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care. 2008;31 Suppl 2:S181–S184. 2. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition. 2001;17:337–346. 3. Nawrot TS, Staessen JA, Roels HA, Den Hond E, Thijs L, Fagard RH, Dominiczak AF, Struijker-Boudier HA. Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J. 2007;28:628–633. 4. Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–241. 5. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, Kantola M, Seppanen K, Rauramaa R. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr. 1988;48:1226 –1232. 6. Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen JK, Karvonen MJ. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol. 1985;122:276 –282. 7. Jossa F, Trevisan M, Krogh V, Farinaro E, Giumetti D, Fusco G, Galasso R, Panico S, Frascatore S, Mellone C, et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis. 1991; 87:129 –134. 8. Coudray C, Roussel AM, Mainard F, Arnaud J, Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J Am Coll Nutr. 1997;16:584 –591. 9. Institute of Medicine (US), Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids : A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Washington, D.C.: National Academy Press; 2000. 10. Combs GF Jr. Selenium in global food systems. Br J Nutr. 2001;85: 517–547. 11. Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: what is new? Curr Opin Lipidol. 2008;19:43– 49. 12. Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med. 2008;168:404–410. 13. Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr. 2008;100:254 –268. 14. Bleys J, Navas-Acien A, Stranges S, Menke A, Miller ER III, Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr. 2008; 88:416–423. 15. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in US adults. Diabetes Care. 2007;30:829–834. 16. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217–223. 17. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ Health Perspect. DOI: 10.1289/ehp.0900704 [epub 2009 May 15]. 18. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Laclaustra et al Selenium and Hypertension in the US Population Services, Centers for Disease Control and Prevention, 2003–2004. Available at: http://www.cdc.gov/nchs/nhanes.htm 19. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Protocol: Selenium. Hyattsville, Md: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003–2004. Reprint: http://www.cdc.gov/nchs/data/nhanes/ nhanes_03_04/l39_c_met_selenium.pdf. 20. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Physician Examination Procedures Manual. Hyattsville, Md: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003–2004. Reprint: http://www.cdc.gov/nchs/data/ nhanes/nhanes_03_04/PE.pdf. 21. Ostchega Y, Prineas RJ, Paulose-Ram R, Grim CM, Willard G, Collins D. National Health and Nutrition Examination Survey 1999–2000: effect of observer training and protocol standardization on reducing blood pressure measurement error. J Clin Epidemiol. 2003;56:768 –774. 22. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey MEC In-Person Dietary Interviewers Procedures Manual. Hyattsville, Md: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003–2004. Reprint: http:// www.cdc.gov/nchs/data/nhanes/nhanes_03_04/DIETARY_MEC.pdf. 23. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Protocol: Cotinine. Hyattsville, Md: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003–2004. Reprint: http://www.cdc.gov/nchs/data/nhanes/ nhanes_03_04/l06_c_met_cotinine.pdf. 24. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR. Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med. 2005;24:2911–2935. 25. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6:356 –365. 26. Lumley, T. Survey: analysis of complex survey samples. R package version 3.6 –13. Available at: http://faculty.washington.edu/tlumley/ survey/. 27. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: http://www.R-project.org. 28. StataCorp. Stata Statistical Software: Release 9.2. College Station Tex, StataCorp LP, 2007. 29. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. 30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206–1252. 31. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84: 762–773. 32. Salvini S, Hennekens CH, Morris JS, Willett WC, Stampfer MJ. Plasma levels of the antioxidant selenium and risk of myocardial infarction among US physicians. Am J Cardiol. 1995;76:1218 –1221. 33. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583–1592. 34. Mark SD, Wang W, Fraumeni JF Jr, Li JY, Taylor PR, Wang GQ, Dawsey SM, Li B, Blot WJ. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology. 1998;9:9 –15. 35. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39 –51. 36. Longnecker MP, Stampfer MJ, Morris JS, Spate V, Baskett C, Mason M, Willett WC. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr. 1993; 57:408 – 413. 376 Circ Cardiovasc Qual Outcomes July 2009. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/6169 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
![]() |
View Item |
Tools
Tools

